Alexander O. Schuth, Chief Operating and Financial Officer and Secretary of Denali Therapeutics Inc., filed a Form 4 on November 19, 2026, disclosing a stock option exercise transaction dated November 17, 2026.
Key Highlights
- Transaction type: Schuth exercised a stock option (transaction code M) covering 16,566 shares of Denali Therapeutics common stock on November 17, 2026.
- Exercise price: The option was exercised at $9.6 per share, with the derivative security price listed as $0.
- Direct ownership after transaction: Schuth directly beneficially owns 295,561 shares of common stock following the reported transaction, including 135,475 unvested RSUs.
- Indirect ownership: An additional 523,749 shares are held indirectly through The Schuth Family Trust U/A DTD 06/05/2017, for which Schuth serves as trustee.
- Remaining options: 40,075 stock options with an exercise price of $9.6 and an expiration date of August 22, 2027 remain beneficially owned directly following the transaction.
- Vesting schedule: According to the filing, 25% of the shares subject to the option vested on August 22, 2018, with an additional 1/48 of the shares vesting monthly thereafter.
Schuth's November 2026 Option Exercise at Denali Therapeutics
Alexander O. Schuth, identified in the filing as COFO and Secretary of Denali Therapeutics Inc. (NASDAQ:DNLI), reported an option exercise on November 17, 2026. According to the Form 4, Schuth acquired 16,566 shares of common stock through a transaction coded "M," indicating a conversion or exercise of a derivative security, at a price of $9.6 per share. The price of the derivative security itself is listed as $0.
Following the reported transaction, the filing states that Schuth directly holds 295,561 shares of common stock, a figure the filing notes includes 135,475 unvested RSUs. Separately, 523,749 shares are held indirectly through The Schuth Family Trust U/A DTD 06/05/2017, with Schuth serving as trustee of that trust. After the exercise, 40,075 stock options with the same $9.6 exercise price and an expiration date of August 22, 2027 remain outstanding in Schuth's direct beneficial ownership.
The filing was signed by Tyler Nielsen pursuant to a power of attorney and submitted on November 19, 2026. The form does not indicate that this transaction was made pursuant to a Rule 10b5-1(c) plan, as the relevant checkbox was not checked.
What Was Disclosed
The filing disclosed that Alexander O. Schuth exercised stock options covering 16,566 shares of Denali Therapeutics common stock on November 17, 2026, at $9.6 per share, leaving 40,075 options remaining and resulting in direct beneficial ownership of 295,561 shares.



Please wait processing your request...